Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 38,518 | 68,036 | 62,749 | 143,835 | 45,440 |
| Cost of Goods | 10,566 | 17,905 | 5,565 | 4,515 | 2,552 |
| Gross Profit | 27,952 | 50,131 | 57,184 | 139,320 | 42,888 |
| Operating Expenses | 24,226 | 21,162 | 25,128 | 27,055 | 24,935 |
| Operating Income | 4,292 | 29,874 | 32,621 | 112,780 | 18,505 |
| Interest Expense | 3,585 | 5,139 | 5,096 | 5,015 | 4,971 |
| Other Income | 1,914 | 6,247 | -2,038 | 6,547 | 212 |
| Pre-tax Income | 2,621 | 30,982 | 25,487 | 114,312 | 13,746 |
| Income Tax | 1,019 | 8,646 | 4,755 | 53,873 | 6,552 |
| Net Income Continuous | 1,602 | 22,336 | 20,732 | 60,439 | 7,194 |
| Minority Interests | N/A | N/A | N/A | N/A | -47 |
| Net Income | $1,602 | $22,336 | $20,732 | $60,439 | $7,241 |
| EPS Basic Total Ops | 0.01 | 0.14 | 0.14 | 0.39 | 0.04 |
| EPS Basic Continuous Ops | 0.01 | 0.14 | 0.14 | 0.39 | 0.04 |
| EPS Diluted Total Ops | 0.01 | 0.14 | 0.14 | 0.39 | 0.04 |
| EPS Diluted Continuous Ops | 0.01 | 0.14 | 0.14 | 0.39 | 0.04 |
| EBITDA(a) | $13,721 | $39,856 | $42,583 | $122,173 | $27,261 |